Full Text
PHP108 CLINICAL EVIDENCE REQUIREMENTS- COMPARISON BETWEEN SEVEN HTA AGENCIES AND IMPLICATIONS FOR DRUG MANUFACTURERS

Abstract

Authors

J Balvanyos K Alnwick C Proudfoot

Back to Volume 13, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×